Numerous enzymes associated with de novo FA synthesis, such as FASN, ACC, and SCD, are frequently overexpressed in various cancers, thereby boosting FA production and contributing to the malignancy of these tumors [24, 25, 26]. This evidence concerns the gene FASN and cancer.